When Hormones Meet Neurodivergence
When Hormones Meet Neurodivergence
Perimenopause is not only a reproductive transition — it is a neurological one. For women with ADHD, this stage can intensify cognitive strain, emotional sensitivity, and physical discomfort. Emerging research published in European Psychiatry suggests that women with ADHD experience more severe and earlier perimenopausal symptoms than women without ADHD. As awareness grows, so does the need for care that recognizes hormones and neurodivergence as deeply intertwined.
Background: The Midlife Shift
Perimenopause is the season leading up to menopause. Estrogen and progesterone fluctuate, then gradually decline.
This hormonal shift can bring:
Brain fog
Sleep disturbance
Mood swings
Anxiety and low mood
Hot flashes and night sweats
Changes in weight and energy
For many women, this unfolds while juggling work, parenting, relationships, and caregiving. It is not a quiet transition. It is a layered one.
ADHD and Estrogen: A Delicate Dance
Estrogen influences dopamine — the neurotransmitter closely tied to attention, motivation, and executive functioning.
When estrogen drops, dopamine signaling shifts.
For women with ADHD, this can mean:
Increased distractibility
Greater emotional reactivity
Heightened overwhelm
More difficulty with planning and organization
Reduced response to stimulant medication
Hormonal change does not create ADHD — but it can magnify it.
What the Research Shows
A large population-based cohort study led by Smári, U. J. (2025) examined perimenopausal symptoms in women with and without ADHD.
The findings were clear:
Women with ADHD reported more severe perimenopausal symptoms overall.
Psychological symptoms were particularly elevated.
Physical and urogenital symptoms were also more common.
Differences appeared earlier — often in the late 30s.
In short, perimenopause may begin sooner and feel stronger for women with ADHD.
Clinical Insight: Hormones Across the Lifespan
Research and clinical guidance from Wynchank, D., de Jong, M., and Kooij, S. J. highlight that hormonal fluctuations affect ADHD symptoms throughout life — during menstrual cycles, postpartum, and (peri)menopause.
Common patterns include:
Cyclical worsening of focus and mood
Increased anxiety or depression
Sleep disruption
Greater emotional intensity
Reduced stimulant effectiveness during hormonal lows
Ignoring these patterns can lead to misdiagnosis or under-treatment.
Cognitive Changes: More Than “Just Brain Fog”
A review by Metcalf, C. A. and colleagues (2023) found that perimenopause commonly affects:
Verbal memory
Processing speed
Attention
Working memory
Sleep disturbance and mood changes may amplify these cognitive shifts.
For women already navigating ADHD-related executive function differences, this convergence can feel destabilizing — even frightening.
Why This Matters
Without a hormone-informed lens:
ADHD may be missed in midlife
Symptoms may be labeled “stress” or “burnout”
Anxiety and depression may be treated in isolation
Women may feel they are losing competence
With awareness:
Hormonal tracking can inform care
ADHD treatment can be adjusted
Sleep and mood can be proactively supported
Cognitive shifts can be normalized
Understanding changes reduces shame.
Conclusion: A Call for Integrated Care
Women with ADHD appear more vulnerable to severe and earlier perimenopausal symptoms.
This is not weakness.
It is biology interacting with neurobiology.
Perimenopause is a recalibration of the brain as much as the body. When clinicians recognize this intersection, care becomes more precise — and more compassionate.
There is still much to learn. Larger trials and clearer guidelines are needed. But the message emerging from the research is steady:
Hormones matter in ADHD.
And women deserve to be heard when they say something has changed.
References
Smári, U. J., Valdimarsdottir, U. A., Wynchank, D., De Jong, M., Aspelund, T., Hauksdottir, A., & Zoega, H. (2025). Perimenopausal symptoms in women with and without ADHD: A population-based cohort study. European Psychiatry, 68(1), e133.
Wynchank, D., de Jong, M., & Kooij, S. J. (2025). Practical tools for female-specific ADHD: The impact of hormonal fluctuations in clinical practice and from the literature. European Psychiatry.
Metcalf, C. A., Duffy, K. A., Page, C. E., & Novick, A. M. (2023). Cognitive problems in perimenopause: A review of recent evidence. Current Psychiatry Reports, 25(10), 501–511.
Rujoiu, P. B. (2023). The effect of sex hormones on attention-deficit/hyperactivity disorder symptoms in women: A systematic review.